-
Something wrong with this record ?
Plasma Levels of Myocardial MicroRNA-133a Increase by Intraoperative Cytokine Hemoadsorption in the Complex Cardiovascular Operation
R. Wagner, P. Soucek, J. Ondrasek, P. Fila, J. Sterba, H. Spacilova, A. Michalcikova, T. Freiberger, P. Nemec,
Language English Country Canada
Document type Journal Article
NLK
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
PubMed
31803323
DOI
10.14740/jocmr3989
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
Background: Complex cardiovascular procedures may initiate a systemic inflammatory response syndrome (SIRS) with a massive cytokine release, which is involved in postoperative myocardial injury. Intraoperative cytokine hemoadsorption (HA) mitigates the inflammatory response. Micro ribonucleic acids (miRNAs) are emerging as a marker of myocardial injury. Methods: This study evaluated if intraoperative cytokine reduction by HA modulates SIRS and affects myocardial injury as measured by miRNA-126, 223 and miRNA-1, 133a, respectively. Twenty-eight patients were assigned into HA (n = 15) and control (C) (n = 13) groups. HA was performed by integrating CytoSorb™ into the extracorporeal circuit. Results: MiRNA-133a plasma levels were increased postoperatively in both groups but were much higher in the HA group than in the C group at 3 h (P = 0.037) and 18 h (P = 0.017) after reperfusion. MiRNA-1 and miRNA-223 plasma levels were significantly increased postoperatively, but did not differ between groups. The vascular miRNA-126 was not affected. Conclusion: Intraoperative cytokine HA in cardiovascular operations increased the plasma levels of miRNA-133a, suggesting higher myocardial injury.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19043951
- 003
- CZ-PrNML
- 005
- 20200109095128.0
- 007
- ta
- 008
- 200107s2019 xxc f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14740/jocmr3989 $2 doi
- 035 __
- $a (PubMed)31803323
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxc
- 100 1_
- $a Wagner, Robert $u Department of Cardiac Anesthesia, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic. These authors contributed equally to this manuscript.
- 245 10
- $a Plasma Levels of Myocardial MicroRNA-133a Increase by Intraoperative Cytokine Hemoadsorption in the Complex Cardiovascular Operation / $c R. Wagner, P. Soucek, J. Ondrasek, P. Fila, J. Sterba, H. Spacilova, A. Michalcikova, T. Freiberger, P. Nemec,
- 520 9_
- $a Background: Complex cardiovascular procedures may initiate a systemic inflammatory response syndrome (SIRS) with a massive cytokine release, which is involved in postoperative myocardial injury. Intraoperative cytokine hemoadsorption (HA) mitigates the inflammatory response. Micro ribonucleic acids (miRNAs) are emerging as a marker of myocardial injury. Methods: This study evaluated if intraoperative cytokine reduction by HA modulates SIRS and affects myocardial injury as measured by miRNA-126, 223 and miRNA-1, 133a, respectively. Twenty-eight patients were assigned into HA (n = 15) and control (C) (n = 13) groups. HA was performed by integrating CytoSorb™ into the extracorporeal circuit. Results: MiRNA-133a plasma levels were increased postoperatively in both groups but were much higher in the HA group than in the C group at 3 h (P = 0.037) and 18 h (P = 0.017) after reperfusion. MiRNA-1 and miRNA-223 plasma levels were significantly increased postoperatively, but did not differ between groups. The vascular miRNA-126 was not affected. Conclusion: Intraoperative cytokine HA in cardiovascular operations increased the plasma levels of miRNA-133a, suggesting higher myocardial injury.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Soucek, Premysl $u Department of Molecular Genetics, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic. These authors contributed equally to this manuscript.
- 700 1_
- $a Ondrasek, Jiri $u Department of Cardiovascular Surgery, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic.
- 700 1_
- $a Fila, Petr $u Department of Cardiovascular Surgery, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic.
- 700 1_
- $a Sterba, Jan $u Department of Cardiovascular Surgery, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic.
- 700 1_
- $a Spacilova, Hana $u Department of Hematological Laboratory, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic.
- 700 1_
- $a Michalcikova, Alzbeta $u Department of Psychology, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic.
- 700 1_
- $a Freiberger, Tomas $u Department of Molecular Genetics, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic.
- 700 1_
- $a Nemec, Petr $u Department of Cardiovascular Surgery, Centre for Cardiovascular and Transplant Surgery (CKTCH), Pekarska 53, Brno, Czech Republic.
- 773 0_
- $w MED00181488 $t Journal of clinical medicine research $x 1918-3003 $g Roč. 11, č. 12 (2019), s. 789-797
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31803323 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200107 $b ABA008
- 991 __
- $a 20200109095457 $b ABA008
- 999 __
- $a ind $b bmc $g 1480540 $s 1082621
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 11 $c 12 $d 789-797 $e 20191124 $i 1918-3003 $m Journal of clinical medicine research $n J Clin Med Res $x MED00181488
- LZP __
- $a Pubmed-20200107